{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:49:42Z","timestamp":1791074982636,"version":"4.1.0"},"reference-count":142,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1378\/chest.10-0167","type":"journal-article","created":{"date-parts":[[2011,5,3]],"date-time":"2011-05-03T01:53:51Z","timestamp":1304387631000},"page":"1172-1185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Pneumonia Due to Pseudomonas aeruginosa"],"prefix":"10.1016","volume":"139","author":[{"given":"Hsin-Yun","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Fujitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Quintiliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor L.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1378\/chest.10-0167_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0732-8893(00)00234-0","article-title":"Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I\u2014results from the SENTRY Antimicrobial Surveillance Program (North America, 1998)","volume":"39","author":"Mathai","year":"2001","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"10.1378\/chest.10-0167_bib2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0732-8893(02)00540-0","article-title":"Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000)","volume":"45","author":"Hoban","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"8","key":"10.1378\/chest.10-0167_bib3","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajic.2004.10.001","article-title":"National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004","volume":"32","author":"National Nosocomial Infections Surveillance System","year":"2004","journal-title":"Am J Infect Control"},{"issue":"10","key":"10.1378\/chest.10-0167_bib4","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1086\/502306","article-title":"Rapidly rising prevalence of nosocomial multidrug-resistant, gram-negative bacilli: a 9-year surveillance study","volume":"25","author":"D'Agata","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"7","key":"10.1378\/chest.10-0167_bib5","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1128\/AAC.48.7.2431-2436.2004","article-title":"Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002","volume":"48","author":"Flamm","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1378\/chest.10-0167_bib6","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1128\/AAC.48.12.4606-4610.2004","article-title":"National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002","volume":"48","author":"Obritsch","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl 2","key":"10.1378\/chest.10-0167_bib7","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1086\/426188","article-title":"Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the United States today surveillance studies","volume":"40","author":"Karlowsky","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1378\/chest.10-0167_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/jac\/dkm129","article-title":"Evolution of antimicrobial resistance among Pseudomonas aeruginosa Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY","volume":"60","author":"Landman","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1378\/chest.10-0167_bib9","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1128\/AAC.01278-06","article-title":"Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients","volume":"51","author":"Reinhardt","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1378\/chest.10-0167_bib10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ijantimicag.2010.08.005","article-title":"In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of intensive care unit patients with nosocomial pneumonia and receiving antipseudomonal therapy","volume":"36","author":"Riou","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"10.1378\/chest.10-0167_bib11","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1086\/339488","article-title":"Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms","volume":"34","author":"Trouillet","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1378\/chest.10-0167_bib12","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.289.7.885","article-title":"Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use","volume":"289","author":"Neuhauser","year":"2003","journal-title":"JAMA"},{"issue":"9","key":"10.1378\/chest.10-0167_bib13","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1046\/j.1469-0691.2003.00690.x","article-title":"Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group","volume":"9","author":"Goossens","year":"2003","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1378\/chest.10-0167_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jcrc.2008.02.001","article-title":"Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes","volume":"23","author":"Parker","year":"2008","journal-title":"J Crit Care"},{"issue":"2","key":"10.1378\/chest.10-0167_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/dkp201","article-title":"Update on the treatment of Pseudomonas aeruginosa pneumonia","volume":"64","author":"El Solh","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1378\/chest.10-0167_bib16","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1469-0691.2007.01681.x","article-title":"Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium","volume":"13","author":"Mesaros","year":"2007","journal-title":"Clin Microbiol Infect"},{"issue":"suppl 1","key":"10.1378\/chest.10-0167_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1469-0691.2007.01865.x","article-title":"Genetic support of extended-spectrum beta-lactamases","volume":"14","author":"Poirel","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1378\/chest.10-0167_bib18","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1128\/CMR.00001-07","article-title":"Carbapenemases: the versatile beta-lactamases","volume":"20","author":"Queenan","year":"2007","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1378\/chest.10-0167_bib19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/QCO.0b013e328303670b","article-title":"Clinically significant carbapenemases: an update","volume":"21","author":"Walsh","year":"2008","journal-title":"Curr Opin Infect Dis"},{"issue":"5","key":"10.1378\/chest.10-0167_bib20","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1128\/AAC.01410-08","article-title":"Extended-spectrum cephalosporinases in Pseudomonas aeruginosa","volume":"53","author":"Rodr\u00edguez-Mart\u00ednez","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1378\/chest.10-0167_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ja.2007.12","article-title":"The mode of action of 2-(thiazol-2-ylthio)-1beta-methylcarbapenems against Pseudomonas aeruginosa: the impact of outer membrane permeability and the contribution of MexAB-OprM efflux system","volume":"60","author":"Eguchi","year":"2007","journal-title":"J Antibiot (Tokyo)"},{"issue":"2","key":"10.1378\/chest.10-0167_bib22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/AAC.49.2.479-487.2005","article-title":"Aminoglycoside resistance in Pseudomonas aeruginosa","volume":"49","author":"Poole","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1378\/chest.10-0167_bib23","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1128\/AAC.48.12.4693-4702.2004","article-title":"Integron carrying a novel metallo-beta-lactamase gene, blaIMP-16, and a fused form of aminoglycoside-resistant gene aac(69)-30\/aac(69)-Ib': report from the SENTRY Antimicrobial Surveillance Program","volume":"48","author":"Mendes","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1378\/chest.10-0167_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0924-8579(01)00466-6","article-title":"Susceptibility to fluoroquinolones among commonly isolated gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today","volume":"19","author":"Karlowsky","year":"2002","journal-title":"Int J Antimicrob Agents"},{"issue":"6A","key":"10.1378\/chest.10-0167_bib25","doi-asserted-by":"crossref","first-page":"45S","DOI":"10.1016\/0002-9343(91)90311-K","article-title":"Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolones","volume":"91","author":"Dudley","year":"1991","journal-title":"Am J Med"},{"issue":"11","key":"10.1378\/chest.10-0167_bib26","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1128\/AAC.47.11.3442-3447.2003","article-title":"Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study","volume":"47","author":"Zanetti","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1378\/chest.10-0167_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ppul.10166","article-title":"Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center","volume":"34","author":"Denton","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.10-0167_bib28","series-title":"Antimicrobial Therapy and Vaccines, Volume II: Antimicrobial Agents","author":"Falagas","year":"2009"},{"issue":"1","key":"10.1378\/chest.10-0167_bib29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00203-009-0528-1","article-title":"Reduced expression of virulence factors in multidrug-resistant Pseudomonas aeruginosa strains","volume":"192","author":"Deptula","year":"2010","journal-title":"Arch Microbiol"},{"issue":"1","key":"10.1378\/chest.10-0167_bib30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1084\/jem.20020005","article-title":"Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa","volume":"196","author":"Hirakata","year":"2002","journal-title":"J Exp Med"},{"issue":"5","key":"10.1378\/chest.10-0167_bib31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/jac\/dkf185","article-title":"Fitness of in vitro selected Pseudomonas aeruginosa nalB and nfxB multidrug resistant mutants","volume":"50","author":"S\u00e1nchez","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1378\/chest.10-0167_bib32","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1128\/AAC.00503-07","article-title":"Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections","volume":"51","author":"Hocquet","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1378\/chest.10-0167_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0732-8893(02)00416-9","article-title":"Pharmacodynamic profiling of continuously infused piperacillin\/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis","volume":"44","author":"Kuti","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"10.1378\/chest.10-0167_bib34","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0924-8579(01)00329-6","article-title":"Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia","volume":"17","author":"Nicolau","year":"2001","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"10.1378\/chest.10-0167_bib35","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.clinthera.2007.11.003","article-title":"Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review","volume":"29","author":"Lorente","year":"2007","journal-title":"Clin Ther"},{"issue":"3","key":"10.1378\/chest.10-0167_bib36","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/510590","article-title":"Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy","volume":"44","author":"Lodise","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1378\/chest.10-0167_bib37","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1128\/AAC.01318-06","article-title":"Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial","volume":"51","author":"Sakka","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1378\/chest.10-0167_bib38","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijantimicag.2006.02.020","article-title":"Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients","volume":"28","author":"Rafati","year":"2006","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1378\/chest.10-0167_bib39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1345\/aph.1G467","article-title":"Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli","volume":"40","author":"Lorente","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1378\/chest.10-0167_bib40","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0002-9610(00)00388-3","article-title":"Intermittent and continuous ceftazidime infusion for critically ill trauma patients","volume":"179","author":"Hanes","year":"2000","journal-title":"Am J Surg"},{"issue":"9","key":"10.1378\/chest.10-0167_bib41","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1128\/AAC.49.9.3624-3630.2005","article-title":"Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa","volume":"49","author":"Tam","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1378\/chest.10-0167_bib42","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1016\/j.clinthera.2009.11.026","article-title":"Probability of pharmacodynamic target attainment with standard and prolonged-infusion antibiotic regimens for empiric therapy in adults with hospital-acquired pneumonia","volume":"31","author":"Kim","year":"2009","journal-title":"Clin Ther"},{"issue":"11","key":"10.1378\/chest.10-0167_bib43","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.clinthera.2008.11.013","article-title":"Stability of doripenem in vitro in representative infusion solutions and infusion bags","volume":"30","author":"Psathas","year":"2008","journal-title":"Clin Ther"},{"issue":"4","key":"10.1378\/chest.10-0167_bib44","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.diagmicrobio.2009.01.026","article-title":"Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp","volume":"63","author":"Castanheira","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"10.1378\/chest.10-0167_bib45","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/CCM.0b013e3181691b99","article-title":"Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study","volume":"36","author":"Chastre","year":"2008","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1378\/chest.10-0167_bib46","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/jac\/dkl512","article-title":"In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates","volume":"59","author":"Owen","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1378\/chest.10-0167_bib47","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/jac\/dkm511","article-title":"Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model","volume":"61","author":"Bergen","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1378\/chest.10-0167_bib48","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1097\/01.CCM.0000275389.31974.22","article-title":"Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy","volume":"35","author":"Garnacho-Montero","year":"2007","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1378\/chest.10-0167_bib49","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1378\/chest.129.5.1210","article-title":"Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia","volume":"129","author":"Kollef","year":"2006","journal-title":"Chest"},{"issue":"1","key":"10.1378\/chest.10-0167_bib50","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/01.TA.0000141890.29032.9A","article-title":"Effect from multiple episodes of inadequate empiric antibiotic therapy for ventilator-associated pneumonia on morbidity and mortality among critically ill trauma patients","volume":"58","author":"Mueller","year":"2005","journal-title":"J Trauma"},{"issue":"7","key":"10.1378\/chest.10-0167_bib51","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00134-004-2292-7","article-title":"Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia: influence of disease severity","volume":"30","author":"Clec'h","year":"2004","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1378\/chest.10-0167_bib52","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00134-002-1603-0","article-title":"Outcome of postoperative pneumonia in the Eole study","volume":"29","author":"Dupont","year":"2003","journal-title":"Intensive Care Med"},{"issue":"12","key":"10.1378\/chest.10-0167_bib53","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1007\/s00134-003-1990-x","article-title":"Impact of adequacy of initial antimicrobial therapy on the prognosis of patients with ventilator-associated pneumonia","volume":"29","author":"Leroy","year":"2003","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1378\/chest.10-0167_bib54","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1128\/AAC.47.9.2756-2764.2003","article-title":"Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia","volume":"47","author":"Chamot","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1378\/chest.10-0167_bib55","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1378\/chest.122.1.262","article-title":"Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia","volume":"122","author":"Iregui","year":"2002","journal-title":"Chest"},{"issue":"2","key":"10.1378\/chest.10-0167_bib56","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s001340000640","article-title":"Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia","volume":"27","author":"Dupont","year":"2001","journal-title":"Intensive Care Med"},{"issue":"12","key":"10.1378\/chest.10-0167_bib57","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1097\/00003246-200112000-00012","article-title":"Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study","volume":"29","author":"Bercault","year":"2001","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1378\/chest.10-0167_bib58","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1378\/chest.115.2.462","article-title":"Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients","volume":"115","author":"Kollef","year":"1999","journal-title":"Chest"},{"issue":"2","key":"10.1378\/chest.10-0167_bib59","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1378\/chest.113.2.412","article-title":"The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia","volume":"113","author":"Kollef","year":"1998","journal-title":"Chest"},{"issue":"2","key":"10.1378\/chest.10-0167_bib60","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1164\/ajrccm.157.2.97-02039","article-title":"Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study","volume":"157","author":"Sanchez-Nieto","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1378\/chest.10-0167_bib61","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1378\/chest.111.3.676","article-title":"Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia","volume":"111","author":"Luna","year":"1997","journal-title":"Chest"},{"issue":"1","key":"10.1378\/chest.10-0167_bib62","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1164\/ajrccm.156.1.9607030","article-title":"The value of routine microbial investigation in ventilator-associated pneumonia","volume":"156","author":"Rello","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1378\/chest.10-0167_bib63","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.41.5.1127","article-title":"Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study","volume":"41","author":"Leibovici","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1378\/chest.10-0167_bib64","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF01712153","article-title":"Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit","volume":"22","author":"Alvarez-Lerma","year":"1996","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1378\/chest.10-0167_bib65","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1159\/000007318","article-title":"Comparison of the bactericidal activity of trovafloxacin and ciprofloxacin, alone and in combination with cefepime, against Pseudomonas aeruginosa","volume":"46","author":"McNabb","year":"2000","journal-title":"Chemotherapy"},{"issue":"11","key":"10.1378\/chest.10-0167_bib66","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1128\/AAC.39.11.2503","article-title":"Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa","volume":"39","author":"Klepser","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1378\/chest.10-0167_bib67","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1128\/AAC.00065-10","article-title":"The combination of meropenem and levofloxacin is synergistic with respect to both Pseudomonas aeruginosa kill rate and resistance suppression","volume":"54","author":"Louie","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1378\/chest.10-0167_bib68","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1128\/AAC.38.3.547","article-title":"Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin","volume":"38","author":"Fink","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1378\/chest.10-0167_bib69","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1172\/JCI200316814","article-title":"Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy","volume":"112","author":"Jumbe","year":"2003","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1378\/chest.10-0167_bib70","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jac\/45.1.57","article-title":"In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa","volume":"45","author":"Bui","year":"2000","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1378\/chest.10-0167_bib71","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/infdis\/146.4.567","article-title":"Third-generation cephalosporins in the treatment of pneumonia due to Pseudomonas aeruginosa in guinea pigs","volume":"146","author":"Pennington","year":"1982","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1378\/chest.10-0167_bib72","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/infdis\/149.6.980","article-title":"Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs","volume":"149","author":"Rusnak","year":"1984","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1378\/chest.10-0167_bib73","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1128\/AAC.31.3.398","article-title":"Evaluation of combination chemotherapy in a lightly anesthetized animal model of Pseudomonas pneumonia","volume":"31","author":"Gordin","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1378\/chest.10-0167_bib74","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/infdis\/158.1.7","article-title":"Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia","volume":"158","author":"Kapusnik","year":"1988","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1378\/chest.10-0167_bib75","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1128\/AAC.43.12.3033","article-title":"Beneficial effect of adjunctive azithromycin in treatment of mucoid Pseudomonas aeruginosa pneumonia in the murine model","volume":"43","author":"Nicolau","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1378\/chest.10-0167_bib76","doi-asserted-by":"crossref","first-page":"213","DOI":"10.14219\/jada.archive.1985.0248","article-title":"Evaluation of an automatic mixing system for an addition silicone impression material","volume":"110","author":"Craig","year":"1985","journal-title":"J Am Dent Assoc"},{"issue":"1","key":"10.1378\/chest.10-0167_bib77","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000237759","article-title":"Antimicrobial synergism in the therapy of gram-negative rod bacteremia","volume":"24","author":"Anderson","year":"1978","journal-title":"Chemotherapy"},{"issue":"3","key":"10.1378\/chest.10-0167_bib78","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0002-9343(80)90102-3","article-title":"Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients","volume":"68","author":"Kreger","year":"1980","journal-title":"Am J Med"},{"issue":"Suppl 1","key":"10.1378\/chest.10-0167_bib79","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1007\/PL00003796","article-title":"Antibiotics in sepsis","volume":"27","author":"Bochud","year":"2001","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1378\/chest.10-0167_bib80","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0002-9343(89)80611-4","article-title":"Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients","volume":"87","author":"Hilf","year":"1989","journal-title":"Am J Med"},{"issue":"7441","key":"10.1378\/chest.10-0167_bib81","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/bmj.38028.520995.63","article-title":"Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials","volume":"328","author":"Paul","year":"2004","journal-title":"BMJ"},{"issue":"8","key":"10.1378\/chest.10-0167_bib82","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(04)01108-9","article-title":"Does combination antimicrobial therapy reduce mortality in gram-negative bacteraemia? A meta-analysis","volume":"4","author":"Safdar","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1378\/chest.10-0167_bib83","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1473-3099(05)70030-X","article-title":"Combination antibiotic therapy for Pseudomonas aeruginosa bacteraemia","volume":"5","author":"Paul","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1378\/chest.10-0167_bib84","first-page":"CD003344","article-title":"Beta lactam antibiotic monotherapy versus beta-lactam aminoglycoside antibiotic combination therapy for sepsis","volume":"25","author":"Paul","year":"2006","journal-title":"Cochrane Database of Syst Rev"},{"issue":"2","key":"10.1378\/chest.10-0167_bib85","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1086\/430912","article-title":"Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials","volume":"41","author":"Bliziotis","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1378\/chest.10-0167_bib86","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1001\/archinte.1985.00360090089015","article-title":"Pseudomonas bacteremia. Retrospective analysis of 410 episodes","volume":"145","author":"Bodey","year":"1985","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1378\/chest.10-0167_bib87","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/archsurg.134.12.1293","article-title":"Analysis of aminoglycosides in the treatment of gram-negative infections in surgical patients","volume":"134","author":"Crabtree","year":"1999","journal-title":"Arch Surg"},{"issue":"1","key":"10.1378\/chest.10-0167_bib88","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1055\/s-2006-933675","article-title":"Should antibiotic combinations be used to treat ventilator-associated pneumonia?","volume":"27","author":"Eggimann","year":"2006","journal-title":"Semin Respir Crit Care Med"},{"issue":"suppl 6","key":"10.1378\/chest.10-0167_bib89","doi-asserted-by":"crossref","first-page":"S320","DOI":"10.1007\/BF01715772","article-title":"Nosocomial pneumonia: comparative multicentre trial between monotherapy with cefotaxime and treatment with antibiotic combinations","volume":"19","author":"Fern\u00e1ndez-Guerrero","year":"1991","journal-title":"Infection"},{"issue":"2","key":"10.1378\/chest.10-0167_bib90","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00005373-199308000-00022","article-title":"Empiric monotherapy versus combination therapy of nosocomial pneumonia in trauma patients","volume":"35","author":"Croce","year":"1993","journal-title":"J Trauma"},{"issue":"1","key":"10.1378\/chest.10-0167_bib91","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.CCM.0000297956.27474.9D","article-title":"Empiric antibiotic therapy for suspected ventilator-associated pneumonia: a systematic review and meta-analysis of randomized trials","volume":"36","author":"Aarts","year":"2008","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1378\/chest.10-0167_bib92","first-page":"1052","article-title":"Efficacy of monotherapy in the treatment of Pseudomonas ventilator-associated pneumonia in patients with trauma","volume":"66","author":"Magnotti","year":"2009","journal-title":"J Trauma"},{"issue":"3","key":"10.1378\/chest.10-0167_bib93","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/01.CCM.0B013E31816203D6","article-title":"Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia","volume":"36","author":"Heyland","year":"2008","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1378\/chest.10-0167_bib94","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1097\/CCM.0b013e3181e96b91","article-title":"A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic\/meta-regression study","volume":"38","author":"Kumar","year":"2010","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1378\/chest.10-0167_bib95","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/clinids\/18.6.886","article-title":"Pseudomonas aeruginosa bacteremia in patients with AIDS","volume":"18","author":"Mendelson","year":"1994","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1378\/chest.10-0167_bib96","doi-asserted-by":"crossref","first-page":"834","DOI":"10.7326\/0003-4819-120-10-199405150-00004","article-title":"Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial","volume":"120","author":"De Pauw","year":"1994","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1378\/chest.10-0167_bib97","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1525-1497.1998.00224.x","article-title":"Risk factors for toxicity in elderly patients given aminoglycosides once daily","volume":"13","author":"Paterson","year":"1998","journal-title":"J Gen Intern Med"},{"issue":"4","key":"10.1378\/chest.10-0167_bib98","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1378\/chest.10-0166","article-title":"Pneumonia due to Pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source","volume":"139","author":"Fujitani","year":"2011","journal-title":"Chest"},{"issue":"1","key":"10.1378\/chest.10-0167_bib99","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0924-8579(98)00060-0","article-title":"Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary","volume":"11","author":"Chow","year":"1999","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1378\/chest.10-0167_bib100","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1128\/AAC.01231-08","article-title":"Beta-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli","volume":"53","author":"Al-Hasan","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"5C","key":"10.1378\/chest.10-0167_bib101","first-page":"53","article-title":"Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam\/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats","volume":"80","author":"Johnson","year":"1986","journal-title":"Am J Med"},{"issue":"3","key":"10.1378\/chest.10-0167_bib102","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0002-9343(84)90100-1","article-title":"Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients","volume":"77","author":"Winston","year":"1984","journal-title":"Am J Med"},{"issue":"5","key":"10.1378\/chest.10-0167_bib103","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1179\/joc.2008.20.5.652","article-title":"Killing activity of rifampin with piperacillin therapy against adherent cells of Pseumodomas aeruginosa","volume":"20","author":"Garey","year":"2008","journal-title":"J Chemother"},{"issue":"6","key":"10.1378\/chest.10-0167_bib104","first-page":"878","article-title":"Addition of rifampin to ticarcillin-tobramycin combination for the treatment of Pseudomonas aeruginosa infections: assessment in a neutropenic mouse model","volume":"103","author":"Zuravleff","year":"1984","journal-title":"J Lab Clin Med"},{"issue":"5","key":"10.1378\/chest.10-0167_bib105","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/infdis\/162.5.1112","article-title":"Comparative therapy with cefpirome alone and in combination with rifampin and\/or gentamicin against a disseminated Pseudomonas aeruginosa infection in leukopenic mice","volume":"162","author":"Valdes","year":"1990","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1378\/chest.10-0167_bib106","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/AAC.26.4.575","article-title":"Addition of rifampin to carboxypenicillin-aminoglycoside combination for the treatment of Pseudomonas aeruginosa infection: clinical experience with four patients","volume":"26","author":"Yu","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1378\/chest.10-0167_bib107","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1128\/AAC.36.3.620","article-title":"Addition of rifampin to combination antibiotic therapy for Pseudomonas aeruginosa bacteremia: prospective trial using the Zelen protocol","volume":"36","author":"Korvick","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1378\/chest.10-0167_bib108","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1086\/657249","article-title":"Use of high dose 4-hour infusion of doripenem in combination with fosfomycin for treatment of carbapenems-resistant Pseudomonas aeruginosa pneumonia","volume":"51","author":"Apisarnthanarok","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1378\/chest.10-0167_bib109","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1469-0691.2009.02901.x","article-title":"Severity of illness scoring systems in patients with bacteraemic pneumococcal pneumonia: implications for the intensive care unit care","volume":"15","author":"Feldman","year":"2009","journal-title":"Clin Microbiol Infect"},{"issue":"2 Pt 1","key":"10.1378\/chest.10-0167_bib110","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1164\/ajrccm.162.2.9909095","article-title":"Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription","volume":"162","author":"Singh","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.10-0167_bib111","author":"Torres"},{"issue":"12","key":"10.1378\/chest.10-0167_bib112","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.7326\/0003-4819-133-12-200012190-00021","article-title":"Management of suspected ventilator-associated pneumonia","volume":"133","author":"Fagon","year":"2000","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1378\/chest.10-0167_bib113","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00134-007-0723-y","article-title":"Antibiotic management of suspected nosocomial ICU-acquired infection: does prolonged empiric therapy improve outcome?","volume":"33","author":"Aarts","year":"2007","journal-title":"Intensive Care Med"},{"issue":"12","key":"10.1378\/chest.10-0167_bib114","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1086\/340533","article-title":"Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli","volume":"34","author":"Harris","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1378\/chest.10-0167_bib115","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10096-009-0850-1","article-title":"Risk factors for multidrug-resistant Pseudomonas aeruginosa acquisition. Impact of antibiotic use in a double case-control study","volume":"29","author":"Montero","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1378\/chest.10-0167_bib116","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1086\/381550","article-title":"Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity","volume":"38","author":"Paramythiotou","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1378\/chest.10-0167_bib117","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/sur.2007.004","article-title":"Pseudomonas aeruginosa susceptible only to colistin in intensive care unit patients","volume":"9","author":"Mastoraki","year":"2008","journal-title":"Surg Infect (Larchmt)"},{"issue":"5","key":"10.1378\/chest.10-0167_bib118","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/514732","article-title":"Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii","volume":"28","author":"Levin","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1378\/chest.10-0167_bib119","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1086\/379611","article-title":"Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa","volume":"37","author":"Linden","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1378\/chest.10-0167_bib120","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1128\/AAC.49.8.3136-3146.2005","article-title":"Combination therapy with intravenous colistin for management of infections due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis","volume":"49","author":"Kasiakou","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1378\/chest.10-0167_bib121","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1183\/09031936.00156906","article-title":"Ventilator-associated pneumonia due to colistin susceptible-only microorganisms","volume":"30","author":"Rios","year":"2007","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1378\/chest.10-0167_bib122","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1007\/s00134-005-2691-4","article-title":"Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study","volume":"31","author":"Reina","year":"2005","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1378\/chest.10-0167_bib123","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1183\/09031936.00102207","article-title":"Colistin as a first choice antibiotic for the initial empiric antimicrobial therapy of ventilator-associated pneumonia","volume":"30","author":"Ioannides","year":"2007","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1378\/chest.10-0167_bib124","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3121\/cmr.4.2.138","article-title":"The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature","volume":"4","author":"Falagas","year":"2006","journal-title":"Clin Med Res"},{"issue":"7","key":"10.1378\/chest.10-0167_bib125","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1007\/s00134-007-0675-2","article-title":"Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study","volume":"33","author":"Kallel","year":"2007","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1378\/chest.10-0167_bib126","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1469-0691.2008.02061.x","article-title":"Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies","volume":"14","author":"Petrosillo","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1378\/chest.10-0167_bib127","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/jac\/dkn530","article-title":"Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa","volume":"63","author":"Aoki","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1378\/chest.10-0167_bib128","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00134-007-0683-2","article-title":"Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa","volume":"33","author":"Mentzelopoulos","year":"2007","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1378\/chest.10-0167_bib129","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1345\/aph.18426","article-title":"Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria","volume":"33","author":"Evans","year":"1999","journal-title":"Ann Pharmacother"},{"issue":"12","key":"10.1378\/chest.10-0167_bib130","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1086\/599225","article-title":"Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center","volume":"48","author":"Hartzell","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1378\/chest.10-0167_bib131","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1155\/2008\/743197","article-title":"Utilization of colistin for treatment of multidrug-resistant Pseudomonas aeruginosa","volume":"19","author":"Sabuda","year":"2008","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"5","key":"10.1378\/chest.10-0167_bib132","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ijid.2006.09.011","article-title":"Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand","volume":"11","author":"Koomanachai","year":"2007","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1378\/chest.10-0167_bib133","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.clinthera.2008.01.015","article-title":"Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study","volume":"30","author":"Markou","year":"2008","journal-title":"Clin Ther"},{"issue":"19","key":"10.1378\/chest.10-0167_bib134","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","article-title":"Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial","volume":"290","author":"Chastre","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1378\/chest.10-0167_bib135","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1378\/chest.122.1.219","article-title":"Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis","volume":"122","author":"Geller","year":"2002","journal-title":"Chest"},{"issue":"3","key":"10.1378\/chest.10-0167_bib136","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10096-008-0620-5","article-title":"Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance","volume":"28","author":"Ghannam","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1378\/chest.10-0167_bib137","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1164\/ajrccm.162.1.9910071","article-title":"Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin","volume":"162","author":"Hamer","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1378\/chest.10-0167_bib138","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s15010-009-9148-6","article-title":"Inhaled anti-infective agents: emphasis on colistin","volume":"38","author":"Michalopoulos","year":"2010","journal-title":"Infection"},{"issue":"3","key":"10.1378\/chest.10-0167_bib139","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.rmed.2007.10.011","article-title":"Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant gram-negative bacteria: a prospective study","volume":"102","author":"Michalopoulos","year":"2008","journal-title":"Respir Med"},{"issue":"suppl 2","key":"10.1378\/chest.10-0167_bib140","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1086\/504485","article-title":"Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia","volume":"43","author":"Linden","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1378\/chest.10-0167_bib141","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1086\/432583","article-title":"Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"41","author":"Kwa","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1378\/chest.10-0167_bib142","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1093\/jac\/dkq360","article-title":"Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by gram-negative bacteria","volume":"65","author":"Rattanaumpawan","year":"2010","journal-title":"J Antimicrob Chemother"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369211602432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369211602432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:23:03Z","timestamp":1757917383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369211602432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":142,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0012369211602432"],"URL":"https:\/\/doi.org\/10.1378\/chest.10-0167","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pneumonia Due to Pseudomonas aeruginosa","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.10-0167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}